Trial Profile
Open label randomized trial of treatment by perospirone and aripiprazole for schizophrenia patients considering the drug susceptibility gene.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Oct 2015
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Perospirone (Primary)
- Indications Schizophrenia
- Focus Pharmacogenomic; Therapeutic Use
- 01 Sep 2015 Results presented at the 28th Annual Congress of the European College of Neuropsychopharmacology
- 09 Oct 2013 Results presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.
- 01 Jan 2013 Results published in Progress in Neuro-Psychopharmacology and Biological Psychiatry.